Tricks of the TradeTrump's Second TermMy EconomyI've Always Wondered ...

Loading...

0:00
0% played
Support the fact-based journalism you rely on with a donation to Marketplace today. Give Now!
Stories Tagged as

Drug companies

"Copay accumulators" put patients in middle of battle between insurers and drugmakers

by Lillian Karabaic
Apr 11, 2024
The tactic helps insurance companies counter high drug prices, but patient advocates are working to ban them. 
“This is an arms race between drug manufacturers and plans, and they keep trying to one up each other,” said Stacie Dusetzina, a professor at Vanderbilt University School of Medicine.
Oleg Elkov via Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Medicare may soon be able to negotiate prescription drug prices

by Matt Levin
Aug 8, 2022
The health policy reform is part of the Democrats' Inflation Reduction Act, which could aid 48 million Medicare recipients.
The Congressional Budget Office estimates that the Inflation Reduction Act will save Medicare $288 billion over the next decade.
Stefani Reynolds/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

The Trump administration wants drug companies to lower prices. This is what’s actually happening.

by Dan Gorenstein
Jul 5, 2018
Pfizer recently raised the list prices for more than 40 of its prescription medications, including the pain med Lyrica. It’s the second time this year Pfizer has boosted list prices. The increases come at a time of increased public and political scrutiny over drug prices. Is Big Pharma not feeling the heat? Click the above […]
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Botox is a multi-billion dollar, potentially deadly monopoly

by Kai Ryssdal , Emily Henderson and Sean McHenry
Oct 31, 2017
The product comes from a substance so lethal that it could be used as a potential agent of bioterrorism.
Andreas Rentz/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE

Why pharma companies are bowing out of generics

by Dan Gorenstein
Aug 2, 2017
Many generic drugs have become so cheap, they have pencil-thin profit margins.
KAREN BLEIER/AFP/Getty Images
ListenLISTEN
HTML EMBED:
COPY
EMBED EMBED
Share Now on:
SHARE
Subscribe Using:
SUBSCRIBE SUBSCRIBE